Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–12 of 12 results
Advanced filters: Author: Lesley Anson Clear advanced filters
    • I-han Chou
    • Tanguy Chouard
    • Lesley Anson
    Editorial
    Nature
    Volume: 444, P: 287
  • We can't make amino acids so they need to form part of our diet. Fortunately, mammals have evolved a taste for these essential protein components, and researchers are beginning to unravel the underlying molecular mechanisms.

    • Lesley Anson
    News & Views
    Nature
    Volume: 416, P: 136
    • Deepa Nath
    • Marie-Thérèse Heemels
    • Lesley Anson
    Editorial
    Nature
    Volume: 444, P: 839
    • Barbara Marte
    • Joshua Finkelstein
    • Lesley Anson
    Editorial
    Nature
    Volume: 445, P: 833
    • Lesley Anson
    News & Views
    Nature
    Volume: 444, P: 156
  • The first bacterial glutamate receptor has been identified, and has an unexpected property: it is very selective for potassium ions. The receptor's amino-acid sequence shows similarity to both glutamate receptors and potassium channels, raising the exciting prospect that both originated from a common ancestor.

    • Lesley Anson
    News & Views
    Nature
    Volume: 402, P: 739
  • The active zones of neurons are characterized in part by protein aggregates that make up 'active-zone material'. The function of this material is unclear, but new high-resolution images look set to change that.

    • Lesley Anson
    News & Views
    Nature
    Volume: 409, P: 467
    • Bernd Pulverer
    • Lesley Anson
    • Liz Allen
    Editorial
    Nature
    Volume: 411, P: 335
    • Lesley Anson
    Editorial
    Nature
    Volume: 440, P: 439
  • Vaccination is effective in protecting from COVID-19. Here the authors report immune responses and breakthrough infections in twice-vaccinated patients receiving anti-TNF treatments for inflammatory bowel disease, and find dampened vaccine responses that implicate the need of adapted vaccination schedules for these patients.

    • Simeng Lin
    • Nicholas A. Kennedy
    • Jeannie Bishop
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-14